news

Stress hormones linked to Crohn’s disease flare-ups

Removing stress hormones in mouse models restored proper function to immune cells and epithelial cells, pointing to new Crohn’s treatments.

Woman holding stomach with intestine illustration highlighted

Researchers at McMaster University, Canada, have found that stress hormones can suppress the innate immune system that normally protects the gut from invasive Enterobacteriaceae, a group of bacteria including E. coli which has been linked to Crohn’s disease. The study, which was conducted in mouse models, could lead to developments in Crohn’s disease treatments.

NEWS: Antibiotic-free hydrogel fights against drug-resistant bacteria

READ HERE

Key to innate immunity is the protective barrier of epithelial cells in the gut which repair the cell wall and secrete mucus, the team explained. Without properly functioning immune cells, the epithelial cellular wall can break down, allowing microbes associated with Crohn’s disease to invade the gut and trigger symptom flare-ups.

The main takeaway is that psychological stress impedes the body’s ability to fight off gut bacteria that may be implicated in Crohn’s disease.”

“The main takeaway is that psychological stress impedes the body’s ability to fight off gut bacteria that may be implicated in Crohn’s disease. Innate immunity is designed to protect us from microbes that do not belong in the gut, like harmful bacteria,” summarised Professor Brian Coombes, senior author of the paper which is published in Nature Communications. “When our innate immune system functions properly, it prevents harmful bacteria from colonising us, but when it breaks down, it leaves an opening for pathogens to colonise locations they normally cannot and cause illness.”

 

Reserve your FREE place

 


Are you advancing promising antibody leads, only to encounter issues with stability, PK or manufacturability later in development?

30 July 2025 | 10:00 AM BST | FREE Webinar

Join us for an expert-led webinar exploring how early-stage developability assessment can help reduce downstream risk and improve candidate selection.

What You’ll Learn:

  • How to identify key developability risks early including aggregation, PK, and manufacturability
  • How to implement high-throughput in vitro assays requiring <1 mg of antibody per test
  • How to combine in silico modeling with wet-lab analytics to guide early optimisation

Don’t miss your chance to learn from Dr Lei Guo.

Register Now – It’s Free!

 

Coombes added that removing stress hormones in the mouse models restored proper function to immune cells and epithelial cells, blocking the invasion of harmful microbes. While this discovery could lead to new treatments for Crohn’s disease, Coombes emphasised that these findings are still at the pre-clinical stage and more work needs to be done. “The more we know about what triggers Crohn’s disease, the closer we come to new treatments and potentially even disease prevention,” he stated.

Leave a Reply

Your email address will not be published. Required fields are marked *